Let’s be honest — cancer is the uninvited guest who overstays their welcome, and the older we get, the more likely they are ...

Former President Biden said the country is in the midst of “dark days” under President Trump. “Friends, I can’t sugarcoat any ...

GSK has acquired the rights to Syndivia’s preclinical antibody drug conjugate (ADC), which is in development for prostate ...

The baffling question: why does prostate cancer relapse quickly in some patients while stabilising in others? Recent ...

An international collaboration of researchers, including Imperial College London and UCLA, has developed a collagen-binding ...

The National Institute for Health and Care Excellence (NICE) has recommended darolutamide in combination with androgen ...

Biden called the current political climate “dark days” but urged Americans to "keep the faith" and “get back up.” ...

GSK has boosted its pipeline of antibody-drug conjugates for cancer, licensing a prostate cancer candidate from Syndivia in a ...

Male breast and prostate cancer need equal awareness. Know symptoms, risks, and why early detection and regular screening are ...

Biotech insiders tout antibody-drug conjugates as the next big thing in cancer treatment, with firms urged to pursue global ...

Former President Joe Biden, in his first public address since finishing prostate cancer treatment, urged “optimism” in a time ...